医药政策法规
- (2021-10-08)
- (2021-10-08)
- (2021-10-08)
- (2021-10-08)
- (2021-10-08)
- (2021-10-08)
- (2021-10-08)
- (2021-09-29)
J IMMUNOTHER CANCER:CTLA4启动子低甲基化在初始诊断时是一种阴性预后生物标记物,但可预测通明细胞肾细胞癌中基于抗PD
(2021-09-29)- (2021-09-29)
- (2021-09-29)
- (2021-09-29)
- (2021-09-29)
- (2021-09-29)
- (2021-09-28)
- (2021-09-28)
- (2021-09-28)
- (2021-09-27)
- (2021-09-27)
- (2021-09-27)
- (2021-09-27)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-26)
- (2021-09-24)
- (2021-09-24)
- (2021-09-24)
- (2021-09-23)
- (2021-09-23)
- (2021-09-23)
- (2021-09-23)
- (2021-09-23)
- (2021-09-23)
- (2021-09-23)
- (2021-09-23)
- (2021-09-23)
- (2021-09-22)
J Natl Compr Canc Netw :原位结直肠癌家族史与侵袭性结直肠癌家族史的紧张性:一项全国性行列步队研讨
(2021-09-22)- (2021-09-22)
- (2021-09-22)
- (2021-09-21)
- (2021-09-21)
- (2021-09-21)
- (2021-09-21)
- (2021-09-21)
- (2021-09-21)
- (2021-09-21)